Literature DB >> 15994918

Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2.

Jun Qian1, Jiong Yang, Aleksandar F Dragovic, Eyad Abu-Isa, Theodore S Lawrence, Ming Zhang.   

Abstract

Specific viral targeting into intrahepatic tumors remains critical for adenovirus gene therapy in liver cancer. We previously showed that ionizing radiation increases adenovirus uptake and transgene expression in cells and colon cancer xenografts. Here, we tested whether radiation induces viral uptake through virus-cell membrane interaction. We found that radiation (8 Gy) induced adenoviral gene transfer in rat hepatocytes (WB) and human colon carcinoma cells (LoVo). This induction (24.4- and 6.5-fold, respectively) and viral uptake were significantly diminished by preincubation with antibody for Dynamin 2 but not for Coxsackie adenovirus receptor or for integrin alpha(v). Radiation-induced Dynamin 2 expression was detected by immunohistochemical staining and by increased mRNA levels for Dynamin 2 in WB (1.5-fold) and LoVo (2.2-fold) cells. Specific small interference RNA (siRNA) transfection significantly inhibited Dynamin 2 expression in various tumor cell lines (LoVo, D54, and MCF-7) and abolished the radiation induction of Dynamin 2. Likewise, radiation-induced viral gene transfer in these cells (6.5-, 5.5-, and 9.0-fold, respectively) was significantly reduced in siRNA-transfected cells (2.7-, 3.7-, and 5.0-fold, respectively). Moreover, viral uptake in LoVo tumor xenografts was significantly increased in s.c. tumors (10.9-fold) when adenovirus was given i.v. at 24 hours after tumor irradiation, coincident with an elevated Dynamin 2 expression in irradiated tumors. These data suggest that ionizing radiation induces adenovirus gene transfer in cells and tumor xenografts by regulating viral uptake, potentially through interaction with cellular Dynamin 2 and thus should provide insight into improving adenovirus targeting in tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994918     DOI: 10.1158/0008-5472.CAN-04-4526

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation.

Authors:  Bing Liu; Hong Zhang; Xiaohong Luo; Yi Xie; Jifang Hao; Qingming Zhou; Xin Duan; Yanling Wang; Weiping Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-16       Impact factor: 4.553

Review 2.  Intelligent design: combination therapy with oncolytic viruses.

Authors:  Kathryn Ottolino-Perry; Jean-Simon Diallo; Brian D Lichty; John C Bell; J Andrea McCart
Journal:  Mol Ther       Date:  2009-12-22       Impact factor: 11.454

3.  Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer.

Authors:  Chunyan Liu; Yonggang Zhang; Minzhi Maggie Liu; Haoming Zhou; Wasim Chowdhury; Shawn E Lupold; Ted L Deweese; Ronald Rodriguez
Journal:  Int J Radiat Biol       Date:  2010-03       Impact factor: 2.694

4.  Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells.

Authors:  R A Abela; J Qian; L Xu; T S Lawrence; M Zhang
Journal:  Cancer Gene Ther       Date:  2008-05-16       Impact factor: 5.987

5.  Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.

Authors:  Vladimir N Ivanov; Hongning Zhou; Tom K Hei
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

6.  Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1.

Authors:  S J Advani; J M Markert; R F Sood; S Samuel; G Y Gillespie; M Y Shao; B Roizman; R R Weichselbaum
Journal:  Gene Ther       Date:  2011-05-05       Impact factor: 5.250

Review 7.  Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice.

Authors:  Omeed Moaven; Christopher W Mangieri; John A Stauffer; Panos Z Anastasiadis; Mitesh J Borad
Journal:  JCO Precis Oncol       Date:  2021-02-24

Review 8.  Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics.

Authors:  K J Harrington; R G Vile; A Melcher; J Chester; H S Pandha
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-12       Impact factor: 7.638

9.  Enhancing the cytotoxicity of chemoradiation with radiation-guided delivery of anti-MGMT morpholino oligonucleotides in non-methylated solid tumors.

Authors:  P Ambady; Y J Wu; J M Walker; C Kersch; M A Pagel; R L Woltjer; R Fu; L L Muldoon; E A Neuwelt
Journal:  Cancer Gene Ther       Date:  2017-07-28       Impact factor: 5.987

Review 10.  Oncolytic Virotherapy: From Bench to Bedside.

Authors:  Ludi Yang; Xiang Gu; Jie Yu; Shengfang Ge; Xianqun Fan
Journal:  Front Cell Dev Biol       Date:  2021-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.